Síndrome de discontinuación de ISRS (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Síndrome de discontinuación de ISRS" in Spanish language version.

refsWebsite

Global rank Spanish rank

28nih.gov

4^th place

24doi.org

2^nd place

4web.archive.org

1^st place

2psychiatrist.com

low place

8,985^th place

1ingentaconnect.com

3,306^th place

2,126^th place

1rcpsych.org

low place

1socialaudit.org.uk

low place

1mhra.gov.uk

low place

1nytimes.com

7^th place

15^th place

1who.int

195^th place

173^rd place

1mediafire.com

4,910^th place

6,730^th place

1benzo.org.uk

low place

1citypages.com

6,216^th place

low place

1springer.com

274^th place

245^th place

1karger.com

4,489^th place

3,175^th place

1psychrights.org

low place

1psychiatryonline.org

4,032^nd place

2,441^st place

1medicalnewstoday.com

3,011^th place

3,464^th place

benzo.org.uk

Healy, David. «Dependence on Antidepressants & Halting SSRIs». Benzo.org.uk. Consultado el 11 de enero de 2014.

citypages.com

«Paxil is Forever – Page 1 – News – Minneapolis». City Pages. 16 de octubre de 2002. Archivado desde el original el 2 de diciembre de 2013. Consultado el 11 de enero de 2014.

doi.org

dx.doi.org

Oliver, J.S.; Burrows; Norman (September 1999). «Discontinuation Syndromes with Selective Serotonin Re-uptake Inhibitors: Are There Clinically Relevant Differences?». CNS Drugs 12 (3): 171-7. doi:10.2165/00023210-199912030-00001. Archivado desde el original el 11 de enero de 2014. (requiere suscripción). |author2= y |last2= redundantes (ayuda); |author3= y |last3= redundantes (ayuda)
Michelson, D.; Fava, M.; Amsterdam, J. et al. (April 2000). «Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial». Br J Psychiatry 176 (4): 363-8. PMID 10827885. doi:10.1192/bjp.176.4.363.
Aronson, J. (8 de octubre de 2005). «Bottled lightning». BMJ 331 (7520): 824. doi:10.1136/bmj.331.7520.824. (requiere registro).
Christmas, M.B. (2005). «'Brain shivers': from chat room to clinic». Psychiatric Bulletin 29 (6): 219-21. doi:10.1192/pb.29.6.219.
Szabadi, E. (1992). «Fluvoxamine withdrawal syndrome». Br J Psychiatry 160 (2): 283-4. PMID 1540778. doi:10.1192/bjp.160.2.283b.
Tamam, L.; Ozpoyraz, N. (2002). «Selective serotonin reuptake inhibitor discontinuation syndrome: a review». Adv Ther 19 (1): 17-26. PMID 12008858. doi:10.1007/BF02850015.
Kaufman, M.J.; Henry, M.E.; Frederick, B.; Hennen, J.; Villafuerte, R.A.; Stoddard, E.P. et al. (2003). «Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study». Biol Psychiatry 54 (5): 534-9. PMID 12946882. doi:10.1016/S0006-3223(02)01828-0.
Damsa, C.; Bumb, A.; Bianchi-Demicheli, F. et al. (August 2004). «"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review». J Clin Psychiatry 65 (8): 1064-8. PMID 15323590. doi:10.4088/JCP.v65n0806.
Haddad, P.M.; Anderson, I.M. (2007). «Recognising and managing antidepressant discontinuation symptoms». Advances in Psychiatric Treatment 13 (6): 447. doi:10.1192/apt.bp.105.001966.
Haddad, P. (2001). «Antidepressant discontinuation syndromes». Drug Saf 24 (3): 183-97. PMID 11347722. doi:10.2165/00002018-200124030-00003.
Fava, G.A.; Bernardi, M.; Tomba, E.; Rafanelli, C. (December 2007). «Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia». Int. J. Neuropsychopharmacology 10 (6): 835-838. PMID 17224089. doi:10.1017/S1461145706007462.
Baboolal, N. (2004). «Venlafaxine withdrawal syndrome: report of seven cases in Trinidad». J Clin Psychopharmacol 24 (2): 229-31. PMID 15206672. doi:10.1097/01.jcp.0000117427.05703.f2.
Parker, G.; Blennerhassett, J. (1998). «Withdrawal reactions associated with venlafaxine». Aust N Z J Psychiatry 32 (2): 291-4. PMID 9588310. doi:10.3109/00048679809062742.
Nissen, C.; Feige, B.; Nofzinger, E.; Riemann, D.; Berger, M.; Voderholzer, U. (2005). «Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine». J Sleep Res 14 (2): 207-8. PMID 15910521. doi:10.1111/j.1365-2869.2005.00447.x.
Tamam, L.; Ozpoyraz, N. (January–February 2002). «Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review». Advances in Therapy 19 (1): 17-26. PMID 12008858. doi:10.1007/BF02850015. Consultado el 28 de noviembre de 2012.
Belaise, Carlotta (2012). «Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders». Psychotherapy and psychosomatics 81 (6): 386-388. PMID 22964821. doi:10.1159/000341178.
Fava G.A.; Bernardi, M.; Tomba, E.; Rafanelli, C. (December 2007). «Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia». Int. J. Neuropsychopharmacol. 10 (6): 835-8. PMID 17224089. doi:10.1017/S1461145706007462.
Csoka, A.; Bahrick; Mehtonen (2008). «Persistent Sexual Dysfunction after Discontinuation of Selective Serotonin Reuptake Inhibitors» (PDF). J Sex Med 5 (5): 227-233. doi:10.1111/j.1743-6109.2007.00630.x. |author2= y |last2= redundantes (ayuda); |author3= y |last3= redundantes (ayuda)
Csoka, A.B.; Bahrick, A.; Mehtonen, O.P. (January 2008). «Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». J Sex Med 5 (1): 227-33. PMID 18173768. doi:10.1111/j.1743-6109.2007.00630.x.
Bolton; Sareen, J.; Reiss, J.P. (2006). «Genital anaesthesia persisting six years after sertraline discontinuation». J Sex Marital Ther. 32 (4): 327-30. PMID 16709553. doi:10.1080/00926230600666410.
Reeves, R.; Mack, J.; Beddingfield, J. (2003). «Shock-like sensations during venlafaxine withdrawal». Pharmacotherapy 23 (5): 678-81. PMID 12741444. doi:10.1592/phco.23.5.678.32198.
Benazzi, F. (1998). «SSRI discontinuation syndrome treated with fluoxetine». Int J Geriatr Psychiatry 13 (6): 421-2. PMID 9658279. doi:10.1002/(SICI)1099-1166(199806)13:6<421::AID-GPS774>3.0.CO;2-Y.
Rosenbaum, J.F.; Fava, M.; Hoog, S.L.; Ashcroft, R.C.; Krebs, W.B. (1998). «Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial». Biol Psychiatry 44 (2): 77-87. PMID 9646889. doi:10.1016/S0006-3223(98)00126-7.
Green B. (2003). «Focus on paroxetine». Curr Med Res Opin 19 (1): 13-21. PMID 12661775. doi:10.1185/030079902125001353.

ingentaconnect.com

Oliver, J.S.; Burrows; Norman (September 1999). «Discontinuation Syndromes with Selective Serotonin Re-uptake Inhibitors: Are There Clinically Relevant Differences?». CNS Drugs 12 (3): 171-7. doi:10.2165/00023210-199912030-00001. Archivado desde el original el 11 de enero de 2014. (requiere suscripción). |author2= y |last2= redundantes (ayuda); |author3= y |last3= redundantes (ayuda)

karger.com

Belaise, Carlotta (2012). «Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders». Psychotherapy and psychosomatics 81 (6): 386-388. PMID 22964821. doi:10.1159/000341178.

mediafire.com

Bahrick, A.S. (2006). «Post SSRI Sexual Dysfunction» (PDF). Tablet (American Society for the Advancement of Pharmacotherapy) 7 (3): 2-10.

medicalnewstoday.com

«Anti-depressants used during pregnancy linked to neonatal withdrawal syndrome». Medical News Today. Lancet. 5 de febrero de 2005.

mhra.gov.uk

MHRA (March/April 2003). «MAIL 136». Archivado desde el original el 30 de agosto de 2009. Consultado el 18 de abril de 2009.

nih.gov

ncbi.nlm.nih.gov

Michelson, D.; Fava, M.; Amsterdam, J. et al. (April 2000). «Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial». Br J Psychiatry 176 (4): 363-8. PMID 10827885. doi:10.1192/bjp.176.4.363.
Young, A.H.; Currie, A. (1997). «Physicians' knowledge of antidepressant withdrawal effects: a survey». J Clin Psychiatry 58 (Suppl 7): 28-30. PMID 9219491.
Szabadi, E. (1992). «Fluvoxamine withdrawal syndrome». Br J Psychiatry 160 (2): 283-4. PMID 1540778. doi:10.1192/bjp.160.2.283b.
Louie, A.K.; Lannon, R.A.; Ajari, L.J. (1994). «Withdrawal reaction after sertraline discontinuation». Am J Psychiatry 151 (3): 450-1. PMID 8109661.
Schatzberg, A.F.; Haddad, P.; Kaplan, E.M.; Lejoyeux, M.; Rosenbaum, J.F.; Young, A.H.; Zajecka, J. (1997). «Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel». J Clin Psychiatry. 5u (7): 5-10. PMID 9219487.
Black, K.; Shea, C.; Dursun, S.; Kutcher, S. (2000). «Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria». J Psychiatry Neurosci 25 (3): 255-61. PMC 1407715. PMID 10863885.
Tamam, L.; Ozpoyraz, N. (2002). «Selective serotonin reuptake inhibitor discontinuation syndrome: a review». Adv Ther 19 (1): 17-26. PMID 12008858. doi:10.1007/BF02850015.
Shelton, R.C. (2006). «The Nature of the Discontinuation Syndrome Associated with Antidepressant Drugs». Journal of Clinical Psychiatry 67 (Suppl 4): 3-7. PMID 16683856. (requiere suscripción).
Kaufman, M.J.; Henry, M.E.; Frederick, B.; Hennen, J.; Villafuerte, R.A.; Stoddard, E.P. et al. (2003). «Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study». Biol Psychiatry 54 (5): 534-9. PMID 12946882. doi:10.1016/S0006-3223(02)01828-0.
Damsa, C.; Bumb, A.; Bianchi-Demicheli, F. et al. (August 2004). «"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review». J Clin Psychiatry 65 (8): 1064-8. PMID 15323590. doi:10.4088/JCP.v65n0806.
Haddad, P. (2001). «Antidepressant discontinuation syndromes». Drug Saf 24 (3): 183-97. PMID 11347722. doi:10.2165/00002018-200124030-00003.
Fava, G.A.; Bernardi, M.; Tomba, E.; Rafanelli, C. (December 2007). «Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia». Int. J. Neuropsychopharmacology 10 (6): 835-838. PMID 17224089. doi:10.1017/S1461145706007462.
Baboolal, N. (2004). «Venlafaxine withdrawal syndrome: report of seven cases in Trinidad». J Clin Psychopharmacol 24 (2): 229-31. PMID 15206672. doi:10.1097/01.jcp.0000117427.05703.f2.
Fava, M.; Mulroy, R.; Alpert, J.; Nierenberg, A.; Rosenbaum, J. (1997). «Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine». Am J Psychiatry 154 (12): 1760-2. PMID 9396960.
Parker, G.; Blennerhassett, J. (1998). «Withdrawal reactions associated with venlafaxine». Aust N Z J Psychiatry 32 (2): 291-4. PMID 9588310. doi:10.3109/00048679809062742.
van Noorden, M.; Vergouwen, A.; Koerselman, G. (2002). «[Delirium during withdrawal of venlafaxine]». Ned Tijdschr Geneeskd 146 (26): 1236-7. PMID 12132141.
Nissen, C.; Feige, B.; Nofzinger, E.; Riemann, D.; Berger, M.; Voderholzer, U. (2005). «Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine». J Sleep Res 14 (2): 207-8. PMID 15910521. doi:10.1111/j.1365-2869.2005.00447.x.
Agelink, M.; Zitzelsberger, A.; Klieser, E. (1997). «Withdrawal syndrome after discontinuation of venlafaxine». Am J Psychiatry 154 (10): 1473-4. PMID 9326838.
Tamam, L.; Ozpoyraz, N. (January–February 2002). «Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review». Advances in Therapy 19 (1): 17-26. PMID 12008858. doi:10.1007/BF02850015. Consultado el 28 de noviembre de 2012.
Belaise, Carlotta (2012). «Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders». Psychotherapy and psychosomatics 81 (6): 386-388. PMID 22964821. doi:10.1159/000341178.
Fava G.A.; Bernardi, M.; Tomba, E.; Rafanelli, C. (December 2007). «Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia». Int. J. Neuropsychopharmacol. 10 (6): 835-8. PMID 17224089. doi:10.1017/S1461145706007462.
Csoka, A.B.; Bahrick, A.; Mehtonen, O.P. (January 2008). «Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». J Sex Med 5 (1): 227-33. PMID 18173768. doi:10.1111/j.1743-6109.2007.00630.x.
Bolton; Sareen, J.; Reiss, J.P. (2006). «Genital anaesthesia persisting six years after sertraline discontinuation». J Sex Marital Ther. 32 (4): 327-30. PMID 16709553. doi:10.1080/00926230600666410.
Reeves, R.; Mack, J.; Beddingfield, J. (2003). «Shock-like sensations during venlafaxine withdrawal». Pharmacotherapy 23 (5): 678-81. PMID 12741444. doi:10.1592/phco.23.5.678.32198.
Benazzi, F. (1998). «SSRI discontinuation syndrome treated with fluoxetine». Int J Geriatr Psychiatry 13 (6): 421-2. PMID 9658279. doi:10.1002/(SICI)1099-1166(199806)13:6<421::AID-GPS774>3.0.CO;2-Y.
Rosenbaum, J.F.; Fava, M.; Hoog, S.L.; Ashcroft, R.C.; Krebs, W.B. (1998). «Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial». Biol Psychiatry 44 (2): 77-87. PMID 9646889. doi:10.1016/S0006-3223(98)00126-7.
Green B. (2003). «Focus on paroxetine». Curr Med Res Opin 19 (1): 13-21. PMID 12661775. doi:10.1185/030079902125001353.

dailymed.nlm.nih.gov

«CYMBALTA (duloxetine hydrochloride) capsule, delayed release». National Institutes of Health, Health & Human Services. julio de 2013. Consultado el 11 de diciembre de 2013.

nytimes.com

Stutz, Bruce (6 de mayo de 2007). «Self-Nonmedication». New York Times. Consultado el 24 de mayo de 2010.

psychiatrist.com

article.psychiatrist.com

Shelton, R.C. (2006). «The Nature of the Discontinuation Syndrome Associated with Antidepressant Drugs». Journal of Clinical Psychiatry 67 (Suppl 4): 3-7. PMID 16683856. (requiere suscripción).
Damsa, C.; Bumb, A.; Bianchi-Demicheli, F. et al. (August 2004). «"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review». J Clin Psychiatry 65 (8): 1064-8. PMID 15323590. doi:10.4088/JCP.v65n0806.

psychiatryonline.org

ajp.psychiatryonline.org

Benazzi, F. (April 1999). «Fluoxetine for Clomipramine Withdrawal Symptoms». Am J Psychiatry 156 (4): 661.

psychrights.org

Csoka, A.; Bahrick; Mehtonen (2008). «Persistent Sexual Dysfunction after Discontinuation of Selective Serotonin Reuptake Inhibitors» (PDF). J Sex Med 5 (5): 227-233. doi:10.1111/j.1743-6109.2007.00630.x. |author2= y |last2= redundantes (ayuda); |author3= y |last3= redundantes (ayuda)

rcpsych.org

pb.rcpsych.org

Christmas, M.B. (2005). «'Brain shivers': from chat room to clinic». Psychiatric Bulletin 29 (6): 219-21. doi:10.1192/pb.29.6.219.

socialaudit.org.uk

Medawar, C.; Herxheimer, A. (2003/2004). «A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine» (PDF reprint). International Journal of Risk & Safety in Medicine 16: 5-19. Archivado desde el original el 21 de octubre de 2013. Consultado el 31 de enero de 2014.

springer.com

link.springer.com

Tamam, L.; Ozpoyraz, N. (January–February 2002). «Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review». Advances in Therapy 19 (1): 17-26. PMID 12008858. doi:10.1007/BF02850015. Consultado el 28 de noviembre de 2012.

web.archive.org

Oliver, J.S.; Burrows; Norman (September 1999). «Discontinuation Syndromes with Selective Serotonin Re-uptake Inhibitors: Are There Clinically Relevant Differences?». CNS Drugs 12 (3): 171-7. doi:10.2165/00023210-199912030-00001. Archivado desde el original el 11 de enero de 2014. (requiere suscripción). |author2= y |last2= redundantes (ayuda); |author3= y |last3= redundantes (ayuda)
Medawar, C.; Herxheimer, A. (2003/2004). «A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine» (PDF reprint). International Journal of Risk & Safety in Medicine 16: 5-19. Archivado desde el original el 21 de octubre de 2013. Consultado el 31 de enero de 2014.
MHRA (March/April 2003). «MAIL 136». Archivado desde el original el 30 de agosto de 2009. Consultado el 18 de abril de 2009.
«Paxil is Forever – Page 1 – News – Minneapolis». City Pages. 16 de octubre de 2002. Archivado desde el original el 2 de diciembre de 2013. Consultado el 11 de enero de 2014.

who.int

apps.who.int

World Health Organization (2003), WHO EXPERT COMMITTEE ON DRUG DEPENDENCE – Thirty-third Report / WHO Technical Report Series 915, World Health Organization .